Rhodin, K. E., Jung, S.-H., Elleson, K., DePalo, D., Straker, R., McKinley, S., … Beasley, G. M. (2023). Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter? In ANNALS OF SURGICAL ONCOLOGY (Vol. 30, pp. S4–S4).

Rhodin, Kristen E., Sin-Ho Jung, Kelly Elleson, Danielle DePalo, Richard Straker, Sophia McKinley, Kate Beekman, et al. “Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?” In ANNALS OF SURGICAL ONCOLOGY, 30:S4–S4, 2023.

Rhodin KE, Jung S-H, Elleson K, DePalo D, Straker R, McKinley S, et al. Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter? In: ANNALS OF SURGICAL ONCOLOGY. 2023. p. S4–S4.

Rhodin, Kristen E., et al. “Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?” ANNALS OF SURGICAL ONCOLOGY, vol. 30, no. SUPPL 1, 2023, pp. S4–S4.

Rhodin KE, Jung S-H, Elleson K, DePalo D, Straker R, McKinley S, Beekman K, Parker L, Chen S, Salama A, Iyer MK, Bartlett EK, Karakousis GC, Zager JS, Tyler DS, Beasley GM. Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter? ANNALS OF SURGICAL ONCOLOGY. 2023. p. S4–S4.